Alexion now officially part of AstraZeneca
New Haven-born Alexion Pharmaceuticals, whose blockbuster blood-disorder drug Soliris made it one of the Elm City’s biggest biotech success stories a decade ago, is now...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
New Haven-born Alexion Pharmaceuticals, whose blockbuster blood-disorder drug Soliris made it one of the Elm City’s biggest biotech success stories a decade ago, is now...
InveniAI® has completed a milestone in its collaboration with PRISM BioLab. The milestone marks completion of the identification and validation of a small molecule drug candidate...
Lauren Zucker is Yale University’s associate vice president for New Haven Affairs and University Properties. New Haven BIZ recently spoke with Zucker about Yale’s efforts to drive...
Rallybio ended the first quarter with nearly $128 million in the bank, and it’s heading to Wall Street for more. The news comes days after...
Stamford health intelligence company Sema4 has completed its business combination with CM Life Sciences, paving the way for the combined company – Sema4 Holdings Corp....
Biorez reports that its proprietary, and recently FDA-cleared BioBrace Implant, received the AOSSM ACE Award for ‘Accelerating the Cutting Edge.’ The award was given at...
There is a growing network of women bioscience leaders in Greater New Haven and across the state. They are hoping to pool their influence to...
In Connecticut, startups — predominantly technology or life sciences ventures located in Greater New Haven — hauled in more than $707 million in funding in...
Thetis Pharmaceuticals reports the launch of a new program in cancer. Thetis CEO Gary Mathias said, “We are targeting pancreatic, metastatic colorectal, small cell lung...
Pain where the jaw hinges to the skull is both common and difficult to treat. Killing off aged cells might be the secret to healing...